Department of Physiology, Ziauddin University, Karachi, Pakistan.
Department of Biochemistry, Ziauddin University, Karachi, Pakistan.
Andrology. 2021 Nov;9(6):1934-1942. doi: 10.1111/andr.13076. Epub 2021 Jul 19.
The difficulties encountered in surgical spermatozoa retrieval for intracytoplasmic sperm injection procedure in azoospermic men have stressed the dire need for a robust biomarker for the prediction of spermatozoa retrieval. Data have highlighted the role of JMJD1A (Jumonji domain-containing 1A), a histone H3K9 demethylase, and other nuclear proteins, protamines (PRM) and transition nuclear proteins (TNP), as biomarkers in male infertility.
To access successful spermatozoa retrieval at the time of intracytoplasmic sperm injection by evaluating the mRNA expression profile of JMJD1A, TNP, and PRM in testicular tissue.
MATERIALS/METHODS: About 100 azoospermic patients, who visited the Australian Concept Infertility Medical Center, Karachi for spermatozoa retrieval by testicular sperm extraction or microsurgical testicular sperm extraction participated in the study. mRNA expression of the JMJD1A, TNP1, TNP2, PRM1, and PRM2 genes was determined. Patients were categorized into successful spermatozoa retrieval (n = 42) group and unsuccessful spermatozoa retrieval (n = 58) group.
Azoospermic men in successful spermatozoa retrieval had significantly increased expression of JMJD1A, TNP2, and PRM2. The hormonal parameters - follicle-stimulating hormone, luteinizing hormone, and thyroid-stimulating hormone were significantly higher in unsuccessful spermatozoa retrieval. Multivariate analysis showed a significant association between JMJD1A, TNP2, PRM2, and successful spermatozoa retrieval. The area under the receiver operating characteristics curve showed a significant discriminatory ability to predict the spermatozoa retrieval outcome in azoospermic patients for mRNA expression of JMJD1A, TNP2, and PRM2 was 71, 72, and 73%, respectively. The area under the curve for follicle-stimulating hormone, luteinizing hormone, and thyroid-stimulating hormone was 0.67, 0.81, and 0.65, respectively.
Our study demonstrates that the mRNA expression profile of JMJD1A, TNP2, and PRM2 along with hormonal parameters, is a useful marker to assess the probability of spermatozoa retrieval before intracytoplasmic sperm injection intervention.
The probability of spermatozoa retrieval in azoospermic patients is increased when the mRNA expression profile of JMJD1A, TNP2, and PRM2 in testicular tissue is increased.
在无精子症男性的胞浆内精子注射程序中,手术获取精子遇到的困难强调了对精子获取的强有力生物标志物的迫切需求。数据突出了 JMJD1A(包含 Jumonji 结构域的 1A)、组蛋白 H3K9 去甲基化酶和其他核蛋白、顶体蛋白(PRM)和过渡核蛋白(TNP)作为男性不育症生物标志物的作用。
通过评估 JMJD1A、TNP 和 PRM 在睾丸组织中的 mRNA 表达谱,评估在胞浆内精子注射时成功获取精子的可能性。
材料/方法:约 100 名因精子获取而前往卡拉奇澳大利亚概念不孕不育医学中心的无精子症患者参加了这项研究,他们通过睾丸精子提取或显微睾丸精子提取获取精子。确定 JMJD1A、TNP1、TNP2、PRM1 和 PRM2 基因的 mRNA 表达。将患者分为成功精子获取(n = 42)组和不成功精子获取(n = 58)组。
成功精子获取的无精子症男性的 JMJD1A、TNP2 和 PRM2 表达显著增加。不成功精子获取的促卵泡激素、黄体生成素和促甲状腺激素的激素参数明显较高。多变量分析显示,JMJD1A、TNP2、PRM2 与成功精子获取之间存在显著关联。接受者操作特征曲线下的面积显示,JMJD1A、TNP2 和 PRM2 的 mRNA 表达对预测无精子症患者精子获取结果具有显著的鉴别能力,分别为 71%、72%和 73%。促卵泡激素、黄体生成素和促甲状腺激素的曲线下面积分别为 0.67、0.81 和 0.65。
我们的研究表明,JMJD1A、TNP2 和 PRM2 的 mRNA 表达谱以及激素参数是在胞浆内精子注射干预之前评估精子获取可能性的有用标志物。
当 JMJD1A、TNP2 和 PRM2 在睾丸组织中的 mRNA 表达谱增加时,无精子症患者精子获取的可能性增加。